American International Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

American International Group’s Portfolio TLIS Stock Details TLIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-490	Closed	-$10K	–	3310
2022 Q1	$10K	Sell	490 -22	-4%	-$761	﹤0.01%	3083
2021 Q4	$31K	Sell	512 -15	-3%	-$1.12K	﹤0.01%	3056
2021 Q3	$49K	Sell	527 -13	-2%	-$1.73K	﹤0.01%	3003
2021 Q2	$89	Buy	540 +26	+5%	+$4.42K	﹤0.01%	2907
2021 Q1	$99	Buy	+514	New	+$128K	﹤0.01%	2727

Other funds holding TLIS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's TLIS Position: Q2 2022 in Review

American International Group sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q2 2022, closing a stake of 490 shares — an estimated $10K sold.

American International Group first reported a position in TLIS in Q1 2021 and held it in 5 quarters. The position peaked at $49K in Q3 2021. 35 funds tracked by Wall St. Rank hold TLIS as of Q2 2022.

American International Group reported no remaining Talis Biomedical Corporation Common Stock position as of Q2 2022 after selling out during the quarter.
American International Group sold 490 Talis Biomedical Corporation Common Stock shares in Q2 2022, an estimated $10K.
American International Group first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 5 quarters.
American International Group's Talis Biomedical Corporation Common Stock position peaked at $49K in Q3 2021.
35 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.